Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-SARS-CoV-2 Spkie protein IgM Antibody (S309)

Catalog #:   RVV00321 Specific References (49) DATASHEET
Host species: Human
Isotype: IgM
Applications: ELISA, Neutralization
Accession: P0DTC2-2
Overview

Catalog No.

RVV00321

Species reactivity

SARS-CoV-2(2019-nCoV)

Host species

Human

Isotype

IgM

Clonality

Monoclonal

Target

Receptor-Binding Domain, RBD, Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, S, SARS-CoV-2, 2019-nCoV

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein L purified from cell culture supernatant.

Accession

P0DTC2-2

Applications

ELISA, Neutralization

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

S309

Data Image
References

The effect of early COVID-19 treatment with convalescent plasma on antibody responses to SARS-CoV-2., PMID:40488473

Post-COVID-19 era sero-surveillance of anti-measles IgM and IgG antibodies among asymptomatic Tanzanian children aged 3 to 15 years Journal., PMID:40455126

Immunological response and implications of Ad26.COV2. S (Janssen COVID-19 vaccine) vaccine in diabetic patients: a prospective cohort study in Ethiopia., PMID:40406137

Analysis of humoral and cellular immune activation up to 21 months after heterologous and homologous COVID-19 vaccination., PMID:40386778

Immune imprinting and vaccine interval determine antibody responses to monovalent XBB.1.5 COVID-19 vaccination., PMID:40382525

Comparative performance of serum and plasma samples in SARS-CoV-2 serology and neutralization assays., PMID:40374015

Mimicking immune complexes for efficient antibody responses., PMID:40356891

Regulatory cytokines modulate early isotype-specific response associated with COVID-19 survival., PMID:40342417

Impact of pre-existing anti-polyethylene glycol (PEG) IgM on biodistribution and humoral response of intramuscularly administered PEGylated mRNA loaded lipid nanoparticle., PMID:40339658

Effectiveness screening of SARS-CoV-2 (COVID-19) in the municipality of Andratx (Balearic Islands, Spain)., PMID:40337727

Geographical Differences in SARS-CoV-2 Antibody Response Dynamics and Neutralisation Profiles to Mild COVID-19: Lessons from a UK-Uganda Comparison., PMID:40333205

Sero-prevalence of SARS-CoV-2 antibodies in Ethiopia: Results of the National Population Based Survey, 2021., PMID:40327714

SARS-CoV-2 Seroprevalence in Indoor House Cats From the Lisbon Area During the COVID-19 Pandemic, 2019-2021., PMID:40303070

Compelling Increase in Parvovirus B19 Infections: Analysis of Molecular Diagnostic Trends (2019-2024)., PMID:40284966

The Clinical and Laboratory Landscape of COVID-19 During the Initial Period of the Pandemic and at the Beginning of the Omicron Era., PMID:40284924

Dynamic Changes in Antibodies and Proteome in Breast Milk of Mothers Infected with Wild-Type SARS-CoV-2 and Omicron: A Longitudinal Study., PMID:40284260

Comparative evaluation of in-house ELISA and two commercial serological assays for the detection of antibodies against SARS-CoV-2., PMID:40263514

Frequency of SARS-CoV-2 antecedent infection in patients with Kawasaki disease., PMID:40256000

Dual-screen-printed electrode platform for simultaneous detection of IgG and IgM antibodies using magnetic beads nanocomplexes., PMID:40250514

Cord blood IgA/M reveals in utero response to SARS-CoV-2 with fluctuations in relation to circulating variants., PMID:40229328

Co-infections and Reactivation of some Herpesviruses (HHV) and Measles Virus (MeV) in Egyptian Cancer Patients infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)., PMID:40214827

Virus-specific antibody responses in severe acute respiratory syndrome coronavirus 2-infected and vaccinated individuals., PMID:40157431

Seroprevalence of anti-SARS-CoV-2 IgG antibodies among children attending the pediatric hospital in Bamako, Mali (BamaCoV-Kids Study)., PMID:40148768

Estimation of Anti-SARS-CoV-2 IgM/IgG Seroprevalence Among Non-Vaccinated and Vaccinated University Students: A Cross-Sectional Egyptian Study., PMID:40143306

Flow cytometric analysis of the SARS coronavirus 2 antibodies in human plasma., PMID:40133428

Rapid detection of systemic and mucosal antibody responses to COVID-19 infection or vaccination., PMID:40132457

In-house assays for detecting anti-SARS-CoV-2 antibodies in serum and urine: Correlation with COVID-19 severity from a cohort study in Qatar., PMID:40117875

Enhanced T-cell immunity and lower humoral responses following 5-dose SARS-CoV-2 vaccination in patients with inborn errors of immunity compared with healthy controls., PMID:40114918

Epidemiology of Parvovirus B19 Infection In an Italian Metropolitan Area, 2012-2024: COVID-19 Pre-Pandemic, Pandemic and Post-Pandemic Trends., PMID:40091525

Korean Red Ginseng relieves the inflammation and oxidative stress induced by pseudo-typed SARS-CoV-2., PMID:40061481

Immune imprinting and vaccination interval underly XBB.1.5 monovalent vaccine immunogenicity., PMID:40034787

Effect of Inactivated Vaccines Against SARS-CoV-2 on Immunogenicity Outcome., PMID:40033891

Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models., PMID:40028815

Rate of vertical transmission of coronavirus disease 2019 and effect of maternal vaccination: A prospective cohort study., PMID:40019392

Rheumatoid arthritis-associated rheumatoid factors post-COVID-19., PMID:40018049

Concordance of maternal and cord blood SARS-COV-2 immunoglobulin seropositivity after COVID-19 infection or vaccination in pregnancy., PMID:39973524

Autoantibodies targeting angiotensin-converting enzyme 2 are prevalent and not induced by SARS-CoV-2 infection., PMID:39950298

Antibodies response in symptomatic and asymptomatic SARS-CoV-2 infected persons in Thailand., PMID:39932922

A novel method for detecting SARS-CoV-2 IgM and IgG based on the gold immune chromatography assay., PMID:39929938

Maternal obesity associates with altered humoral immunity in blood and colostrum., PMID:39870213

An allelic atlas of immunoglobulin heavy chain variable regions reveals antibody binding epitope preference resilient to SARS-CoV-2 mutation escape., PMID:39840032

Antibody responses in omicron BF.7-infected patients vaccinated with inactivated SARS-CoV-2., PMID:39824066

The protective effect of serum antibodies in preventing SARS-CoV-2 virus entry into cardiac muscle., PMID:39808173

Individual patient and donor seroprofiles in convalescent plasma treatment of COVID-19 in REMAP-CAP clinical trial., PMID:39798805

Serological insights from SARS-CoV-2 heterologous prime and boost responses in Thailand., PMID:39789037

Assessment of Humoral Response at SARS-CoV-2 Infection by Multipronged Functional Proteomics Approaches., PMID:39772566

Neutralizing antibody test supports booster strategy for young individuals after SARS-CoV-2 Omicron breakthrough., PMID:39757187

[Analysis of CMV and EBV infection in healthy populations in China before and after the COVID-19 pandemic]., PMID:39746690

Autoantibodies in hospitalised patients with COVID-19., PMID:39734590

Datasheet
$ 484
Product specifications
100 μg 484 1 mg 1932

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-SARS-CoV-2 Spkie protein IgM Antibody (S309) [RVV00321]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only